Skip to main content
. Author manuscript; available in PMC: 2021 Nov 21.
Published in final edited form as: Lancet. 2020 Nov 10;396(10263):1637–1643. doi: 10.1016/S0140-6736(20)32332-1

Figure 4: Effect of LDL cholesterol lowering on the risk of safety endpoints in older patients.

Figure 4:

Older patients were aged 75 years or older. Data are n or n/N (%), unless otherwise indicated. RRs per 1 mmol/L reduction in LDL cholesterol were generated from a random effects model. The numbers of patients without cancer events per treatment group were not available in the Cholesterol Treatment Trialists’ Collaboration meta-analysis. The definitions of reported safety data in each trial are given in the appendix (p 18). RR=risk ratio.